Back to top
more

Moderna (MRNA)

(Real Time Quote from BATS)

$146.62 USD

146.62
17,509,881

-12.21 (-7.69%)

Updated Aug 26, 2026 02:54 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value A Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (157 out of 247)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Indrajit Bandyopadhyay headshot

Pausing of AstraZeneca's Coronavirus Study Aids Pfizer, Moderna

by Indrajit Bandyopadhyay

The pause in AstraZeneca's (AZN) voluntary coronavirus study following an adverse event provides its competitors a breather.

Zacks Equity Research

Moderna Gets Rating Downgrade, Takes Safety Pledge, Stock Down

by Zacks Equity Research

Moderna (MRNA) pledges with eight other pharma companies to ensure commercialization of a safe and effective vaccine. However, anticipated competitive pressure weighs on the stock.

Kinjel Shah headshot

CEOs of Nine Coronavirus Vaccine Makers Sign Safety Pledge

by Kinjel Shah

The COVID-19 vaccine developers pledge to observe high ethical standards and sound scientific principles in conducting clinical studies and manufacturing of vaccines.

Kinjel Shah headshot

Coronavirus Vaccine Efforts Hit as AstraZeneca Halts Study

by Kinjel Shah

Amid rising optimism on timely approval of a safe vaccine, the vaccine development efforts of AstraZeneca (AZN) have hit a roadblock.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Moderna, Sanofi, GSK, GILD and AMGN

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Moderna, Sanofi, GSK, GILD and AMGN

Zacks Equity Research

Tech Stumbles, CEO's Pledge Safe Vaccine Trial

by Zacks Equity Research

Tech Stumbles, CEO's Pledge Safe Vaccine Trial

Mark Vickery headshot

Tesla's Snub, Vaccine-Makers' Pledge

by Mark Vickery

The S&P 500 is down 50 points, the Dow -260 and the tech-heavy Nasdaq off by a whopping 400 points -- nearly 3.5%.

Kinjel Shah headshot

Coronavirus Vaccine Makers May Make Joint Safety Pledge

by Kinjel Shah

The vaccine developers are likely to pledge to observe high ethical standards in conducting clinical studies and manufacturing of the vaccines, the Wall Street report said.

Zacks Equity Research

Why Is Moderna (MRNA) Down 12.1% Since Last Earnings Report?

by Zacks Equity Research

Moderna (MRNA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Ritujay Ghosh headshot

Vaccine Hopes Rise Again: 4 Stocks to Watch

by Ritujay Ghosh

The United States is ensuring adequate doses of the Coronavirus vaccine once it is developed. Some companies leading the race are Moderna, Inc. (MRNA), Pfizer, Inc. (PFE) and Sanofi (SNY).